Abstract submission guidelines

1. Abstracts may only be submitted in English. Submission can only be carried out online, via the conference website on the provided form. Submissions by fax, email or postal mail will not be accepted. Following submission, the corresponding author will receive an automated email confirmation to acknowledge receipt of the abstract.

2. Each submission can have more than one author. These must include a corresponding author (who assumes responsibility for submission) and a presenting author (who will deliver the presentation/poster at the conference). These may or may not be one and the same person. Please remember to specify accordingly.

3. When preparing your abstract, be guided by the norms of scientific writing.

4. All abbreviations must be defined the first time they appear in the text.

5. Abbreviations must not be used in the title.

6. Tables, figures and references should not be used.

7. Use generic names for drugs or medical equipment. Commercial names may not be used unless they are imperative to the scientific value of the study.

8. The authors must disclose any significant financial or other relationship with the manufacturer(s) of any commercial product(s) or service(s) discussed in their presentation, by filling in any relevant details in the Disclosure field on the submission form. If no such relationship exists, enter “None” into this field. Further information on the statement of disclosure can be found under the corresponding page.

9. Authors should indicate their presentation preference - Poster Presentation (to be considered for short talks - scientific sessions) or Poster Presentation (not considered for a short talk) - as well as the speciality under which they wish their abstract to be categorised.

Important points

1. Please make sure that the email address you provide does not belong to an account that is often full and therefore bounces back messages.

2. Once an abstract is submitted, it cannot be electronically retracted by any author. If an author wishes to retract a submitted abstract, he/she should email mmsc@um.edu.mt with the request, indicating the full title of the abstract. Only the designated corresponding author has the authority to request retraction of a submitted abstract.

3. The authors must attest to and are solely responsible for the authenticity of the submitted abstract. However, the corresponding author is deemed to assume responsibility for all the authors, and in the event of any such requirement, the XI Malta Medical School Scientific Committee will only enter into correspondence with the designated corresponding author.

4. The abstract should be meticulously proofread before submitting.

5. The spelling of all author names and the sequence in which they are listed should be carefully checked.

6. The submission of an abstract constitutes a commitment by the authors to present their work at assigned times at the Conference, if accepted.

7. Case reports are acceptable, especially if they offer:

Novel insights (e.g., rare presentations, unexpected outcomes)
Educational value (highlighting diagnostic or therapeutic challenges)
Innovative management or use of emerging therapies
A launchpad for broader discussion (e.g., implications for guidelines or future research)

8. Any expenses associated with the preparation and/or submission of an abstract, are the sole responsibility of the authors.

After submission

1. A submission confirmation email will be automatically sent to the corresponding author. Please note that automatic e-mail confirmation may sometimes be blocked by corporate networks or spam filters. In case of difficulty, please email mmsc@um.edu.mt

2. Notification of abstract acceptance and selected type of presentation will be later sent electronically to the corresponding author.

Reviewing procedure and selection

1. Submitted abstracts will be reviewed by the Scientific Committee, and will be evaluated on the basis of originality, scientific value and relevance to clinical care and biomedical sciences.

2. The Scientific Committee reserves the right to reject abstracts, and to choose between oral or poster presentations for accepted submissions.

3. The Scientific Committee reserves the right to allocate accepted presentations to speciality areas which may be different to those recommended by the authors.

4. The decisions of the Scientific Committee are final

Submission Deadline 19 September, 2025

Early Bird Registration Deadline 30 September, 2025

Conference Date 04-06 December, 2025